These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29662319)

  • 1. Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis.
    Zhao W; Zang C; Zhang T; Li J; Liu R; Feng F; Lv Q; Zheng L; Tian J; Sun C
    Onco Targets Ther; 2018; 11():1821-1831. PubMed ID: 29662319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and prognostic impact of aldehyde dehydrogenase 1 in non-small cell lung cancer: a meta-analysis.
    Xue J; Zhao Y; Zou Q; Liang F; Lin F
    Transl Cancer Res; 2020 Mar; 9(3):1914-1925. PubMed ID: 35117538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
    Li D; Cao Y; Luo CW; Zhang LP; Zou YB
    Recent Pat Anticancer Drug Discov; 2024; 19(5):599-609. PubMed ID: 37818578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
    Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
    Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of ALDH1 expression in lung cancer: a meta-analysis.
    Huo W; Du M; Pan X; Zhu X; Li Z
    Int J Clin Exp Med; 2015; 8(2):2045-51. PubMed ID: 25932135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Chen J; Xia Q; Jiang B; Chang W; Yuan W; Ma Z; Liu Z; Shu X
    PLoS One; 2015; 10(12):e0145164. PubMed ID: 26682730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
    Zhou C; Sun B
    Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH1 Expression and the Prognosis of Lung Cancer: A Systematic Review and Meta-Analysis.
    Wei D; Peng JJ; Gao H; Zhang T; Tan Y; Hu YH
    Heart Lung Circ; 2015 Aug; 24(8):780-8. PubMed ID: 25921687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of cancer stem-like cell biomarker aldehyde dehydrogenase-1 (ALDH1) in ovarian cancer: A meta-analysis.
    Ruscito I; Darb-Esfahani S; Kulbe H; Bellati F; Zizzari IG; Rahimi Koshkaki H; Napoletano C; Caserta D; Rughetti A; Kessler M; Sehouli J; Nuti M; Braicu EI
    Gynecol Oncol; 2018 Jul; 150(1):151-157. PubMed ID: 29753392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.
    Ma YM; Zhao S
    Onco Targets Ther; 2016; 9():1981-8. PubMed ID: 27110126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of the cancer stem cell marker CD117 predicts poor prognosis in epithelial ovarian cancer patients: evidence from meta-analysis.
    Yang B; Yan X; Liu L; Jiang C; Hou S
    Onco Targets Ther; 2017; 10():2951-2961. PubMed ID: 28652777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
    Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
    Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis.
    Li Z; Yin S; Zhang L; Liu W; Chen B; Xing H
    Onco Targets Ther; 2017; 10():859-870. PubMed ID: 28243121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.
    Fang J; Guo X; Zheng B; Han W; Chen X; Zhu J; Xie B; Liu J; Luan X; Yan Y; He Z; Li H; Qiao C; Yu J
    Arch Gynecol Obstet; 2018 Feb; 297(2):449-458. PubMed ID: 29274004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis.
    Zhang W; Zhang Z; Qian L
    World J Surg Oncol; 2024 Jan; 22(1):8. PubMed ID: 38172843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis.
    Razmi M; Ghods R; Vafaei S; Sahlolbei M; Saeednejad Zanjani L; Madjd Z
    Cancer Cell Int; 2021 Feb; 21(1):139. PubMed ID: 33639931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Clinicopathological Significance of PD-L1 in Patients With Bladder Cancer: A Meta-Analysis.
    Zhu L; Sun J; Wang L; Li Z; Wang L; Li Z
    Front Pharmacol; 2019; 10():962. PubMed ID: 31616289
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.